Patient Opportunity Trust A (LGOAX)
41.25
+0.42
(+1.03%)
USD |
Jul 03 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 1.74% | 1.637B | 1.01% | 31.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -130.56M | 23.57% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term growth of capital by investing in securities, derivatives and other financial instruments that, in the Fund's adviser's opinion, offer the opportunity for long-term growth of capital. Further, the Fund may sell securities short and utilize a practice known as "leveraging". |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US |
| Peer Group | Multi-Cap Core Funds |
| Global Macro | Equity North America |
| US Macro | Multi-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Growth & Income Funds |
| Fund Owner Firm Name | Patient Capital Management |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
71
-1.665B
Peer Group Low
949.50M
Peer Group High
1 Year
% Rank:
74
-130.56M
-6.231B
Peer Group Low
21.51B
Peer Group High
3 Months
% Rank:
69
-4.537B
Peer Group Low
22.38B
Peer Group High
3 Years
% Rank:
81
-11.01B
Peer Group Low
46.05B
Peer Group High
6 Months
% Rank:
75
-2.633B
Peer Group Low
36.84B
Peer Group High
5 Years
% Rank:
78
-31.83B
Peer Group Low
89.32B
Peer Group High
YTD
% Rank:
75
-2.633B
Peer Group Low
36.84B
Peer Group High
10 Years
% Rank:
82
-56.23B
Peer Group Low
265.29B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of July 07, 2025.
Asset Allocation
As of March 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.03% |
| Stock | 93.79% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 1.24% |
| Other | 4.94% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Amazon.com Inc | 6.12% | 223.41 | 1.59% |
| Citigroup Inc | 5.46% | 88.72 | 2.26% |
| QXO Inc | 5.42% | 21.98 | 1.81% |
| Alphabet Inc | 5.25% | 179.53 | 0.50% |
| Royalty Pharma PLC | 5.05% | 36.37 | 0.50% |
| Energy Transfer LP | 5.05% | 17.97 | 0.39% |
| CVS Health Corp | 4.84% | 67.43 | 1.25% |
| Meta Platforms Inc | 4.66% | 719.01 | 0.76% |
| IAC Inc | 4.27% | 38.81 | -1.45% |
| General Motors Co | 4.03% | 52.89 | 0.40% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | 0.25% |
| Actual Management Fee | 0.75% |
| Administration Fee | 474.1K% |
| Maximum Front Load | 5.75% |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 1000.00 None |
| Minimum Subsequent Investment | 50.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term growth of capital by investing in securities, derivatives and other financial instruments that, in the Fund's adviser's opinion, offer the opportunity for long-term growth of capital. Further, the Fund may sell securities short and utilize a practice known as "leveraging". |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US |
| Peer Group | Multi-Cap Core Funds |
| Global Macro | Equity North America |
| US Macro | Multi-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Growth & Income Funds |
| Fund Owner Firm Name | Patient Capital Management |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (7-2-25) | 0.05% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | 17.03 |
| Weighted Average Price to Sales Ratio | 6.380 |
| Weighted Average Price to Book Ratio | 3.937 |
| Weighted Median ROE | 20.91% |
| Weighted Median ROA | 7.51% |
| ROI (TTM) | 10.44% |
| Return on Investment (TTM) | 10.44% |
| Earning Yield | 0.0800 |
| LT Debt / Shareholders Equity | 1.309 |
As of March 31, 2025
Growth Metrics
| EPS Growth (1Y) | 29.68% |
| EPS Growth (3Y) | 5.34% |
| EPS Growth (5Y) | 10.63% |
| Sales Growth (1Y) | 10.23% |
| Sales Growth (3Y) | 15.72% |
| Sales Growth (5Y) | 13.23% |
| Sales per Share Growth (1Y) | 5.92% |
| Sales per Share Growth (3Y) | 10.98% |
| Operating Cash Flow - Growth Ratge (3Y) | 47.55% |
As of March 31, 2025
Fund Details
| Key Dates | |
| Inception Date | 12/30/1999 |
| Last Annual Report Date | 12/31/2024 |
| Last Prospectus Date | 4/30/2025 |
| Share Classes | |
| LMNOX | Inst |
| LMOFX | Other |
| LMOPX | C |
| LMORX | Retirement |
| MVISX | Other |
| Attributes | |
| Index Fund | -- |
| Inverse Fund | -- |
| Leveraged Fund | -- |
| Fund of Funds | No |
| Currency Hedged Fund | -- |
| Synthetic Replication Fund | No |
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:LGOAX", "name") |
| Broad Asset Class: =YCI("M:LGOAX", "broad_asset_class") |
| Broad Category: =YCI("M:LGOAX", "broad_category_group") |
| Prospectus Objective: =YCI("M:LGOAX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |